Flood alleviation company Flodef plans to move into large-scale
manufacturing after gaining BSI Kitemark accreditation for its
product last week.
Flodef claims it produces the only flood alleviation system for
individual properties, especially in cases where a civil
engineering project is not viable. The system's inventor John
Lockwood told CJ: "The problem with diverting water is that it can
make flooding worse elsewhere."
He described the system as a "roller blind upside down", which
protects buildings above and below ground. A flexible membrane is
installed underground in a duct around the perimeter of the
building. During a flood warning, the membrane is pulled up in
sections into supports in the building's walls, and air seals at
the sides of each section are inflated. The company said the system
can be erected by one person in 30 to 40 minutes.
Lockwood chose butyl rubber for the membrane because of its
performance in pond liner applications. UV stability,
anti-microbial performance and strength were also important
factors.
He said research and development work included eight months getting
the product watertight. "I found water to be one of the most
caustic substances. Most sealants that claim to be waterproof are
only shower-proof. We had to turn to large companies like Bostik
Findley and the marine industry to find suitable sealants."
Results were well within the Kitemark standard; the product leaked
0.37 litres/m/h in 900mm of static water.
Flodef's bespoke systems accommodate a building's shape, including
windows and doors.
For new buildings, Lockwood said the barrier is sealed inside
cavity walls and integrated into the level entrance required under
Part M of the Building Regulations.
The system costs between £12,000 and £20,000 to install
in a small four-bedroom house, and around £40,000 for a small
commercial building, including surveys, installations and
training.
The Association of British Insurers estimates there are currently
more than two million homes within a flood risk area. Flodef is
talking to insurance companies and the ABI about the product's
potential.